ProbioMed Kids | Meltingargerlar | 10 Billion CFU | Heilsubarinn

ProbioMed Kids | Meltingargerlar | 10 Billion CFU

5.990 kr

ProbioMed Kids | Meltingargerlar | 10 Billion CFU

5.990 kr
Thumbnail for ProbioMed Kids | Meltingargerlar | 10 Billion CFU | Heilsubarinn Thumbnail for ProbioMed Kids | Meltingargerlar | 10 Billion CFU | Heilsubarinn
ProbioMed Kids | Meltingargerlar | 10 Billion CFU | Heilsubarinn
ProbioMed Kids | Meltingargerlar | 10 Billion CFU | Heilsubarinn

ProbioMed Kids | Meltingargerlar | 10...

5.990 kr

• 10 milljarðar CFU af 11 meltingargerla stofnum
• Inniheldur Lactobacillus, Bifidobacterium og Saccharomyces boulardii
• Tuggutöflur með berjabragði, sætt með monk fruit
• Krefst ekki kælingar
• Fyrir börn 4 ára og eldri

Frí sending yfir 15 þúsund krónur. Pantanir eru afgreiddar samdægurs ef pantað er fyrir kl. 13, annars daginn eftir (virka daga). Ekki er afgreitt um helgar. Þær eru afhentar með Dropp, á þann stað sem þú velur.

Örugg greiðslulausn með Saltpay eða Netgíró.

Auðveld skil með Dropp.
Nánari Lýsing

ProbioMed™ Kids er breiðvirk, hágæða meltingargerla blanda sem er sérhönnuð til að styðja við örveruflóru og ónæmisheilsu barna.

Miklar örverubreytingar eiga sér stað í þörmum þegar barn vex frá ungbarni til unglings sem krefst oft stuðnings til að byggja upp fjölbreytileika baktería og styðja við meltingarfæri og ónæmisheilsu.

Ýmsir þættir, eins og sýklalyfjanotkun snemma á ævinni, einhæft mataræði og sýkingar, geta truflað þetta þarmabakteríujafnvægi.

ProbioMed™ Kids inniheldur 11 fjölbreytta, vel rannsakaða Lactobacillus og Bifidobacterium probiotic bakteríu stofna, ásamt Saccharomyces boulardii (S. boulardii).  Þessi formúla skilar 10 milljörðum CFU af örverum á skammt, og er magn hvers stofns skýrt gefið upp.

Hver tuggutafla hefur ljúffengt bragð af blönduðum berjum og er sætt með monk fruit extract og inniheldur engin gervilitarefni eða bragðefni.

Þó að varan sé ætluð börnum 4 ára og eldri, er hún einnig hentug fyrir fullorðna sem kjósa tuggutöflu form.

ÍTARLEGRI UPPLÝSINGAR

Börn 4 ára og eldri: Tyggið 1 töflu á dag með máltíð eða samkvæmt leiðbeiningum heilbrigðisstarfsmanns.

1. Davis EC, Dinsmoor AM, Wang M, Donovan SM. Microbiome composition in pediatric populations from birth to adolescence: impact of diet and prebiotic and probiotic interventions. Dig Dis Sci. 2020;65(3):706722. doi:10.1007/s10620-020-06092-x.

2. Korpela K, Salonen A, Virta LJ, Kumpu M, Kekkonen RA, de Vos WM. Lactobacillus rhamnosus GG intake modifies preschool children's intestinal microbiota, alleviates penicillin-associated changes, and reduces antibiotic use. PLoS One. 2016;11(4):e0154012. doi:10.1371/journal.pone.0154012.

3. Guo Q, Goldenberg JZ, Humphrey C, El Dib R, Johnston BC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2019;4(4):CD004827. Published 2019 Apr 30. doi:10.1002/14651858.CD004827.pub5.

4. Nixon AF, Cunningham SJ, Cohen HW, Crain EF. The effect of Lactobacillus GG on acute diarrheal illness in the pediatric emergency department. Pediatr Emerg Care. 2012;28(10):1048-1051. doi:10.1097/ PEC.0b013e31826cad9f.

5. Basu S, Paul DK, Ganguly S, Chatterjee M, Chandra PK. Efficacy of high-dose Lactobacillus rhamnosus GG in controlling acute watery diarrhea in Indian children: a randomized controlled trial. J Clin Gastroenterol. 2009;43(3):208-213. doi:10.1097/MCG.0b013e31815a5780.

6. Guandalini S, Pensabene L, Zikri MA, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr. 2000;30(1):54-60. doi:10.1097/00005176-200001000-00018.

7. Sansotta N, Peroni DG, Romano S, et al. The good bugs: the use of probiotics in pediatrics. Curr Opin Pediatr. 2019;31(5):661-669. doi:10.1097/MOP.0000000000000808.

8. Ahmadi E, Alizadeh-Navaei R, Rezai MS. Efficacy of probiotic use in acute rotavirus diarrhea in children: a systematic review and meta-analysis. Caspian J Intern Med. 2015;6(4):187-195.

9. Näse L, Hatakka K, Savilahti E, et al. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res. 2001;35(6):412420. doi:10.1159/000047484.

10. Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy. 2000;30(11):1604-1610. doi:10.1046/j.1365-2222.2000.00943.x.

11. Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003;361(9372):1869-1871. doi:10.1016/ S0140-6736(03)13490-3.

12. Kalliomäki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119(4):10191021. doi:10.1016/j.jaci.2006.12.608.

13. Cosenza L, Nocerino R, Di Scala C, et al. Bugs for atopy: the Lactobacillus rhamnosus GG strategy for food allergy prevention and treatment in children. Benef Microbes. 2015;6(2):225-232. doi:10.3920/BM2014.0158.

14. Rianda D, Agustina R, Setiawan EA, Manikam NRM. Effect of probiotic supplementation on cognitive function in children and adolescents: a systematic review of randomised trials. Benef Microbes. 2019;10(8):873-882. doi:10.3920/BM2019.0068.

15. Pärtty A, Kalliomäki M, Wacklin P, Salminen S, Isolauri E. A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatr Res. 2015;77(6):823-828. doi:10.1038/pr.2015.51.

16. Näse L, Hatakka K, Savilahti E, et al. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res. 2001;35(6):412420. doi:10.1159/000047484.

17. Glavina D, Gorseta K, Skrinjarić I, Vranić DN, Mehulić K, Kozul K. Effect of LGG yoghurt on Streptococcus mutans and Lactobacillus spp. salivary counts in children. Coll Antropol. 2012;36(1):129-132.

18. Kumpu M, Kekkonen RA, Kautiainen H, et al. Milk containing probiotic Lactobacillus rhamnosus GG and respiratory illness in children: a randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr. 2012;66(9):1020-1023. doi:10.1038/ejcn.2012.62.

19. Hatakka K, Savilahti E, Pönkä A, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ. 2001;322(7298):1327. doi:10.1136/ bmj.322.7298.1327.

20. Hojsak I, Snovak N, Abdović S, Szajewska H, Misak Z, Kolacek S. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clin Nutr. 2010;29(3):312-316. doi:10.1016/j.clnu.2009.09.008.

21. Sanders ME. Summary of probiotic activities of Bifidobacterium lactis HN019. J Clin Gastroenterol. 2006;40(9):776-783. doi:10.1097/01.mcg.0000225576.73385.f0.

22. Hemalatha R, Ouwehand AC, Saarinen MT, Prasad UV, Swetha K, Bhaskar V. Effect of probiotic supplementation on total lactobacilli, bifidobacteria and short chain fatty acids in 2–5-year-old children. Microb Ecol Health Dis. 2017;28(1):1298340. doi:10.1080/16512235.2017.1298340.

23. Liu C, Zhang ZY, Dong K, Guo XK. Adhesion and immunomodulatory effects of Bifidobacterium lactis HN019 on intestinal epithelial cells INT-407. World J Gastroenterol. 2010;16(18):2283-2290. doi:10.3748/wjg. v16.i18.2283.

24. Sazawal S, Dhingra U, Hiremath G, et al. Prebiotic and probiotic fortified milk in prevention of morbidities among children: community-based, randomized, double-blind, controlled trial. PLoS One. 2010;5(8):e12164. doi:10.1371/journal.pone.0012164.

25. Sazawal S, Dhingra U, Hiremath G, et al. Effects of Bifidobacterium lactis HN019 and prebiotic oligosaccharide added to milk on iron status, anemia, and growth among children 1 to 4 years old. J Pediatr Gastroenterol Nutr. 2010;51(3):341-346. doi:10.1097/MPG.0b013e3181d98e45.

26. Aggarwal S, Upadhyay A, Shah D, Teotia N, Agarwal A, Jaiswal V. Lactobacillus GG for treatment of acute childhood diarrhoea: an open labelled, randomized controlled trial. Indian J Med Res. 2014;139(3):379-385.


© 2026 Heilsubarinn ehf. Allur réttur áskilinn.